INTEGRA Biosciences’ reagent dispenser now supports SiLA-2 integration

INTEGRA Biosciences’ WELLJET reagent dispenser now supports API commands based on the SiLA-2 standardized communication protocol for lab automation. This new functionality will make it even easier to integrate the WELLJET into automated laboratory workflows, helping labs to enhance their productivity and reproducibility.

Eli Lilly to acquire Morphic for $3.2 billion

Eli Lilly said Monday it will acquire Morphic Holding, a biotech developing a treatment for inflammatory bowel disease. Lilly will pay about $3.2 billion to

July 8, 2024

The ironic origin story behind Sloan Kettering

In the spring of 1945, Alfred P. Sloan, the former CEO of General Motors, made what seemed like a magnanimous gesture. He donated $4 million

February 21, 2025

AbbVie concludes acquisition of ImmunoGen for $10.1bn

Share this article ImmunoGen’s pipeline complements the existing oncology portfolio of AbbVie. Credit: JHVEPhoto / Shutterstock.com. AbbVie has completed the acquisition of ImmunoGen for $10.1bn,

February 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.